K. Takahashi

发表

Resistance of infant leukemia with MLL rearrangement to tumor necrosis factor-related apoptosis-inducing ligand: a possible mechanism for poor sensitivity to antitumor immunity

K. Goi, S. Nakazawa, K. Okumura, 2006, Leukemia.

Relapsed acute promyelocytic leukemia previously treated with all-trans retinoic acid: clinical experience with a new synthetic retinoid, Am-80.

R. Ueda, M. Harada, K. Shudo, 1998, Leukemia & lymphoma.

Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML

Z. Estrov, G. Garcia-Manero, J. Cortes, 2013, Leukemia.

Extensive cytogenetic studies of clonality following interferon-α therapy in chronic myeloid leukemia occurring in monosomic cells in a patient with Turner syndrome mosaic

R. Ohno, H. Matsui, A. Takeshita, 1999, Leukemia.

Influence of IDH on FLT3-ITD status in newly diagnosed AML

M. Konopleva, H. Kantarjian, J. Cortes, 2017, Leukemia.

Little impact of donor/recipient major mismatch for neutrophil-specific antigen NA2 on neutrophil recovery after allogeneic SCT

K. Goi, S. Nakazawa, T. Inukai, 2009, Bone Marrow Transplantation.

Clonotypic analysis of acute lymphoblastic leukemia with a double TEL-AML1 fusion at onset and relapse

K. Goi, S. Nakazawa, T. Inukai, 2006, Leukemia.

S149: LONG TERM OUTCOMES OF IFCG REGIMEN FOR FIRSTLINE TREATMENT OF PATIENTS WITH CLL WITH MUTATED IGHV AND WITHOUT DEL(17P)/TP53 MUTATION

M. Konopleva, Z. Estrov, T. Kadia, 2022, HemaSphere.